Cerus Corporation (CERS) vs Contineum Therapeutics, Inc. (CTNM)

A side-by-side comparison of Cerus Corporation and Contineum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cerus Corporation logo
CERS
Cerus Corporation
$476M
$2.36HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Contineum Therapeutics, Inc. logo
CTNM
Contineum Therapeutics, Inc.
$471M
$12.52HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT

Total return — CERS vs CTNM

growth of $100 · dividends reinvested · last 2y
CERS +30.7% (+14.3%/yr)CTNM -17.4% (-9.1%/yr)CERS compounded faster over this window
50100150Start $10020252026$131$83
CERS CTNM

CERS vs CTNM: by the numbers

  • •CERS is the larger company ($476M vs $471M market cap).
  • •Both run net losses; CTNM's is the smaller (0.00% vs -3.06% net margin).

Metrics side by side

Valuation

MetricCERSCTNM
P/S ratio2.15N/A
P/B ratio6.791.97
EV / EBITDA8097.24N/A

Profitability

MetricCERSCTNM
Gross margin52.05%0.00%
Operating margin-0.73%0.00%
Net margin-3.06%0.00%
ROE-9.69%-24.02%
ROIC-1.08%-27.22%

Growth (annualized)

MetricCERSCTNM
Revenue CAGR (5Y)15.74%N/A
Total return CAGR (5Y)-17.30%N/A

Go deeper

Full CERS analysisFull CTNM analysisInteractive comparison tool

Dig into the metrics

Cerus ROEContineum Therapeutics ROECerus operating marginContineum Therapeutics operating marginCerus revenue growthContineum Therapeutics revenue growthCerus free cash flowContineum Therapeutics free cash flow

Cerus & Contineum Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.